VJLabs has been awarded an NIH R21 grant to advance xenotransplantation research using organ-on-a-chip technology.

VJLabs published a milestone paper in Advanced Materials on our immunocompetent liver Tissueoid platform.

The Terasaki Institute welcomed the Royal Belgian Economic Mission and Ghent University, strengthening international collaboration in biomedical innovation.

The Terasaki Institute and Cal State Northridge launched a new partnership to advance biomedical research education and training.

VJLabs developed a 3D microphysiological system that models pericyte-induced temozolomide resistance in glioblastoma.

A new microfluidic-based biosensing platform for real-time monitoring of monoclonal antibody cellular secretion, developed with UT San Antonio.

A human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents.

A new organ-on-a-chip platform recapitulating age-dependent immune responses for evaluating cancer vaccine performance in older adults.

The Terasaki Institute was awarded a $2.3 million grant from NIH for organ transplantation research using organs-on-a-chip technology.

Mayo Clinic and the Terasaki Institute launched a collaboration to advance transplant innovation through organ-on-a-chip technologies.

Dr. Jucaud delivered a talk celebrating his mentor's life and moderated a Fireside Chat with leaders from UCLA, Cedars-Sinai, and One Lambda.

TIBI received an NIH grant to develop an allograft rejection-on-a-chip model for studying immune-mediated graft injury.

Development of screen-printed electrodes for real-time TEER measurement of endothelial barrier integrity in organ-on-a-chip devices.

The Terasaki Institute received a grant from METAvivor to support metastatic breast cancer research.